Latest Cardiovascular Disease (CVD) News
The USPSTF guidelines focus statin recommendations on 38% of high-risk African American individuals at the expense of not recommending treatment in nearly 25% of African Americans.
Men taking PDE5 lowered their risk of hospitalization and mortality after a heart attack by 33%.
In short-term treatment duration, there was no increased risk of myocardial infarction stroke or heart failure using DPP-4i vs SU/TZD.
Patients with early and frequent nephrology visits before dialysis initiation had about a 10% lower risk for major adverse cardiovascular events.
No evidence to determine whether taking herbal medications cause complications among patients with CVD.
No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI.
Plasma TMAO levels among patients predict both near- and long-term risks of incident cardiovascular events.
Participants with high TG and low HDL levels had a 1.32-fold greater HR for CHD than those with normal TG and normal HDL levels.
In a large study, testosterone replacement therapy was associated with a 33% lower risk of cardiac and stroke events among hypogonadal men.
The presence of CAC among individuals aged between 32 and 46 years was associated with increased risk of fatal and nonfatal CHD during 12.5 years of follow-up.
Those without traditional cardiovascular risk factors are disproportionately prone to these cardiac diseases in the setting of alcohol abuse.
Adjusted rates of hospitalization for AF increased by almost 1% per year between 1999 and 2013.
Irregular eating patterns appear less favorable for achieving a healthy cardiometabolic profile.
Baseline LDL-C was lower in patients with LDL-C <25 versus ≥25 mg/dl.
Patients with an eGFR below 60 mL/min/1.73 m2 were more likely to die in the hospital or be discharged to hospice.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)